Search

everythinglearnresearchcommunity

for

Search:↓

Some treatments can help hair regrowth in alopecia areata, but none offer a cure, and effectiveness varies.

Regenerative treatments for vitiligo show promise but need more research for long-term safety and effectiveness.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

Topical immunomodulators are effective and safe for treating immune-related skin conditions.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Nonimmunosuppressive cyclosporines might treat skin diseases by affecting cell growth.

Immunoadsorption successfully treated a man's resistant polymyositis.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Immunosuppression therapy with methylprednisolone effectively treats childhood alopecia areata.

Methotrexate can temporarily suppress certain immune responses without killing immune cells, potentially helping treat autoimmune diseases.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Long-term use of calcineurin inhibitors in transplant patients can cause hormone issues that can be managed with proper care.

Combining glucocorticoids with immunosuppressants like cyclophosphamide improves remission and reduces relapse in pemphigus patients.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Some people with heavy hair shedding might actually have a hidden form of alopecia, which can be identified by specific hair changes.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Pimecrolimus reduces the effectiveness of stem cell therapy for atopic dermatitis.

Prednisone has risks for lupus patients, isotretinoin is safe for mental health, transplant patients risk skin cancer, and various treatments are effective for specific skin conditions.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

Combining cytostatic and steroid drugs effectively treats systemic lupus erythematosus.